CLINICAL_TRIALS
trial_result
· 2019-04-04
Clinical Trial Update: 6-week Safety and PD Study in Adults With NAFLD [Phase 2]
Summary
Phase 2 safety and pharmacodynamic study in adults with non-alcoholic fatty liver disease completed; results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Pfizer | Conditions: Non-alcoholic Fatty Liver Disease | Phase 2 | Status: COMPLETED | Results posted: 2019-04-04